HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
F Raspagliesi Selected Research
F Raspagliesi Research Topics
Disease
12
Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 05/2001
10
Neoplasms (Cancer)
01/2022 - 12/2001
7
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 01/2002
7
Carcinoma (Carcinomatosis)
03/2013 - 05/2001
5
Ovarian Epithelial Carcinoma
01/2022 - 05/2001
2
Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 11/2015
2
Pain (Aches)
01/2018 - 11/2006
1
Peripheral Nervous System Diseases (PNS Diseases)
01/2018
1
Ascites
11/2017
1
Neoplasm Metastasis (Metastasis)
10/2016
1
Disease Progression
01/2016
1
Lymphatic Metastasis
03/2013
1
Margins of Excision
08/2011
1
Bowen's Disease (Disease, Bowen)
11/2006
1
Basal Cell Carcinoma (Rodent Ulcer)
11/2006
1
Edema (Dropsy)
11/2006
1
Type 2 Diabetes Mellitus (MODY)
09/2005
1
Sarcoma (Soft Tissue Sarcoma)
11/2004
1
Vulvar Neoplasms (Vulvar Cancer)
05/2003
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2002
1
Dysgerminoma
12/2001
1
Granulosa Cell Tumor
12/2001
1
Testicular Neoplasms (Testicular Cancer)
12/2001
1
Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2001
1
Carcinogenesis
12/2001
1
Residual Neoplasm
05/2001
Drug/Important Bio-Agent (IBA)
4
Platinum
IBA
01/2018 - 01/2006
3
Paclitaxel (Taxol)
FDA Link
Generic
01/2016 - 01/2002
2
Monoclonal Antibodies
IBA
01/2022 - 01/2022
2
Epitopes
IBA
01/2022 - 01/2022
2
Mucin-1 (CA 15-3 Antigen)
IBA
01/2022 - 01/2022
2
Trabectedin
IBA
11/2017 - 03/2016
2
Cisplatin (Platino)
FDA Link
Generic
03/2013 - 05/2001
1
ErbB Receptors (EGF Receptor)
IBA
01/2022
1
Carbohydrates
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
Bevacizumab (Avastin)
FDA Link
10/2020
1
pembrolizumab
IBA
01/2019
1
Glycoproteins (Glycoprotein)
IBA
11/2017
1
Orosomucoid (Seromucoid)
IBA
11/2017
1
PM 01183
IBA
11/2017
1
Proteins (Proteins, Gene)
FDA Link
11/2017
1
trebananib
IBA
01/2016
1
Indocyanine Green (Cardio-Green)
FDA Link
Generic
11/2015
1
Topotecan (Hycamtin)
FDA Link
Generic
03/2013
1
Acids
IBA
11/2006
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
11/2006
1
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
11/2006
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2006
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2006
1
liposomal doxorubicin (Doxil)
FDA Link
01/2006
1
Blood Glucose (Blood Sugar)
IBA
09/2005
1
Glucose (Dextrose)
FDA Link
Generic
09/2005
1
Solutions
IBA
05/2003
1
Coloring Agents (Dyes)
IBA
05/2003
1
Folic Acid (Vitamin M)
FDA Link
Generic
01/2003
1
Inhibins (Inhibin)
IBA
12/2001
1
Tumor Biomarkers (Tumor Markers)
IBA
12/2001
1
Activins (Activin)
IBA
12/2001
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
05/2001
Therapy/Procedure
6
Drug Therapy (Chemotherapy)
01/2022 - 08/2006
5
Hysterectomy
01/2021 - 08/2011
5
Cytoreduction Surgical Procedures
07/2014 - 05/2001
4
Therapeutics
01/2022 - 01/2005
3
Radiotherapy
01/2022 - 01/2002
2
Lymph Node Excision (Lymph Node Dissection)
10/2016 - 05/2003
2
Neoadjuvant Therapy
10/2016 - 08/2015
2
Adjuvant Chemotherapy
03/2013 - 01/2012
1
Photochemotherapy (Photodynamic Therapy)
11/2006
1
Combination Drug Therapy (Combination Chemotherapy)
01/2006
1
Salvage Therapy
05/2001